Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Change In Payables And Accrued Expense?

Laboratorio Farmaceutico Erfo SpA's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was €0.00 Mil. It means Laboratorio Farmaceutico Erfo SpA's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

Laboratorio Farmaceutico Erfo SpA's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means Laboratorio Farmaceutico Erfo SpA's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Laboratorio Farmaceutico Erfo SpA Change In Payables And Accrued Expense Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Change In Payables And Accrued Expense Chart

Laboratorio Farmaceutico Erfo SpA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial					-	-	-	-	-

Laboratorio Farmaceutico Erfo SpA Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Laboratorio Farmaceutico Erfo SpA Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049

Website

https://www.erfo.it

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines